Delivery Order SPE2DB24D2011-SPE2DB24FBPLV

Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a Delivery Order valued at $2,495.95 for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award was made by the Defense Logistics Agency (DLA), which is a defense agency, for fulfillment by May 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, as well as a smaller IDC with the...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order contract worth $17,278.79 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This Delivery Order contract has a firm fixed price and an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,531.30 under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a completion date of December 19, 2024. This award is part of Amerisourcebergen's broader IDC with the DLA, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract valued at $3,371.19 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, to support military healthcare programs. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a $263,299.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, with a ceiling value of $2,697.62, is a Delivery Order from the Defense Logistics Agency (DLA), a defense agency, for the delivery of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 23, 2024....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The $2,171.62 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,228.50 firm fixed-price delivery order is for WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA). The $3,662.22 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a period of performance through May 15, 2025. The award is not designated as a set-aside and represents an open competition contract. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $12,376.56 and is a firm fixed price delivery order set to expire on June 11, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBPLV
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $3,302.82 for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD) that provides logistics, acquisition, and technical services.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract award is not designated as a set-aside. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 7/22/24, 9:22 AM